Tissue-Engineering the Intestine: The Trials before the Trials.

Journal: Cell Stem Cell

Published: 2019-06-06

DOI: 10.1016/j.stem.2019.04.018

Affiliations: 18

Authors: 9

Go to article
Institutions Share
StemCell Technologies, Inc., Canada 0.11
Tumour Cell Biology Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.11
Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, United Kingdom (UK) 0.11
UCL Stem Cells and Regenerative Medicine Section, United Kingdom (UK) 0.06
EPFL Institute of Chemical Sciences and Engineering (ISIC), Switzerland 0.06
Danish Stem Cell Center (Danstem), UCPH, Denmark 0.06
Department of Surgery, University of Cambridge, United Kingdom (UK) 0.06
Paediatric and Neonatal Intensive Care Unit (PICU/NICU), GOSH, United Kingdom (UK) 0.06
Biotech Research and Innovation Centre (BRIC), UCPH, Denmark 0.06
Wellcome Trust - MRC Cambridge Stem Cell Institute, University of Cambridge, United Kingdom (UK) 0.06
EPFL Laboratory of Stem Cell Bioengineering (LSCB), Switzerland 0.06
Hubrecht Institute: Developmental Biology and Stem Cell Research, KNAW, Netherlands 0.04
Princess Maxima Centre for Pediatric Oncology (PMC), Netherlands 0.04
Oncode Institute, Netherlands 0.04
USC Developmental Biology and Regenerative Medicine Research Program, United States of America (USA) 0.03
USC Department of Surgery, United States of America (USA) 0.03
USC Children's Hospital Los Angeles (CHLA), United States of America (USA) 0.03
USC Keck School of Medicine, United States of America (USA) 0.03